Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) Enterprise Value (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Enterprise Value readings, the most recent being -$2.1 billion for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 8.74% to -$2.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.1 billion, a 8.74% increase, with the full-year FY2025 number at -$4.3 billion, down 59.19% from a year prior.
  • Enterprise Value hit -$2.1 billion in Q1 2026 for GE HealthCare Technologies, up from -$4.3 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$277.0 million in Q1 2022 to a low of -$4.3 billion in Q4 2025.
  • Median Enterprise Value over the past 5 years was -$2.3 billion (2023), compared with a mean of -$2.2 billion.
  • Biggest five-year swings in Enterprise Value: tumbled 670.04% in 2023 and later grew 8.74% in 2026.
  • GE HealthCare Technologies' Enterprise Value stood at -$1.2 billion in 2022, then plummeted by 91.73% to -$2.3 billion in 2023, then fell by 15.55% to -$2.7 billion in 2024, then crashed by 59.19% to -$4.3 billion in 2025, then skyrocketed by 52.0% to -$2.1 billion in 2026.
  • The last three reported values for Enterprise Value were -$2.1 billion (Q1 2026), -$4.3 billion (Q4 2025), and -$4.0 billion (Q3 2025) per Business Quant data.